Patents by Inventor Malcolm A Meyn, III

Malcolm A Meyn, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel cell-derived composition
    Publication number: 20170035812
    Abstract: The invention is directed to a novel cell-derived composition having bone growth, regeneration, and repair promoting properties. In particular, the invention is directed to a novel cell-derived composition having bone growth, regeneration, and repair promoting properties termed Amnion-derived Cellular Cytokine Solution-B (ACCS-B). The invention is further directed to the use of this novel composition to promote bone growth and/or regeneration and/or repair.
    Type: Application
    Filed: October 10, 2016
    Publication date: February 9, 2017
    Applicant: Noveome Biotherapeutics, Inc.
    Inventors: Malcolm A Meyn, III, Christopher A Fried, Donna M Olejniczak, Randall G Rupp
  • Cell-derived composition
    Patent number: 9464272
    Abstract: The invention is directed to a cell-derived composition having bone growth, regeneration, and repair promoting properties. In particular, the invention is directed to a cell-derived composition having bone growth, regeneration, and repair promoting properties termed Amnion-derived Cellular Cytokine Solution-B (ACCS-B). The invention is further directed to the use of this composition to promote bone growth and/or regeneration and/or repair.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: October 11, 2016
    Assignee: STEMNION, INC.
    Inventors: Malcolm A Meyn, III, Christopher A Fried, Donna M Olejniczak, Randall G Rupp
  • Novel Cell Compositions and Methods
    Publication number: 20150196603
    Abstract: The invention is directed to novel cell compositions termed AMP-N cells. In particular, the invention is directed to novel AMP-N cell compositions and novel compositions derived from the AMP-N cells including, but not limited to, novel cell-derived conditioned medium, termed ACCS-N. The invention is further directed to novel methods for making the novel AMP-N cell and ACCS-N compositions as well as uses thereof.
    Type: Application
    Filed: August 2, 2013
    Publication date: July 16, 2015
    Applicant: STEMNION, INC.
    Inventors: Victoria Grammer, Malcolm A Meyn, III, Randall G. Rupp
  • Novel Cell-derived Composition
    Publication number: 20150166951
    Abstract: The invention is directed to a novel cell-derived composition having bone growth, regeneration, and repair promoting properties. In particular, the invention is directed to a novel cell-derived composition having bone growth, regeneration, and repair promoting properties termed Amnion-derived Cellular Cytokine Solution-B (ACCS-B). The invention is further directed to the use of this novel composition to promote bone growth and/or regeneration and/or repair.
    Type: Application
    Filed: December 11, 2014
    Publication date: June 18, 2015
    Applicant: STEMNION, INC.
    Inventors: Malcolm A Meyn, III, Christopher A Fried, Donna M Olejniczak, Randall G Rupp